Tempest Therapeutics, Inc. - Common Stock, par value $0.001 per share (TPST)

CUSIP: 87978U207

Q1 2026 13F Holders as of 31 Mar 2026

Security type / class
Equity / Common Stock, par value $0.001 per share
Total 13F shares
517,131
Total reported value
$848,109
Holder snapshot 6 facts
Share change
-139,957
Reported price per share
$1.64
Number of holders
20
Value change
-$242,423
Number of buys
4
Number of sells
5
Security identity 1 fact
Shares outstanding
13,473,733

Security key

87978U207

Report period

Q1 2026

Institutions

20

Top holders

10

TPST full security history Ownership snapshot Full 13F holder table Previous quarter: Q4 2025 Tempest Therapeutics, Inc. SEC filings Tempest Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of TPST - Tempest Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
Matthew Angel
13D/G signal
Matthew Angel
Evidence rows
15
Latest as of
24 Mar 2026
3/4/5 13D/G 13F Lead comparable stake: 37% 13D/G row: Matthew Angel Showing 1-6 of 15 holder rows.
Holder Evidence Ownership % Position 12M Net Δ As of
Matthew Angel
3/4/5 13D/G
CEO and President, Director, 10%+ Owner
3/4/5 13D/G
37%
from 13D/G
$38,112,971
13,606,668 shares
mixed-class rows
 +$500,001 24 Mar 2026
SABBY MANAGEMENT, LLC
13D/G 13F
Company
13D/G 13F
9.9%
$1,397,913
492,223 shares
 $0 31 Dec 2025
Versant Venture Capital VI, L.P.
3/4/5 13D/G
10%+ Owner · Versant Vantage II, L.P.
3/4/5 13D/G
1.1%
from 13D/G
$2,562,608
2,328,585 shares
 — 08 Aug 2024
Versant Venture Management, LLC
13F
Company
13F
1.8%
$774,246
269,772 shares
 — 31 Dec 2025
VANGUARD GROUP INC
13F
Company
13F
1.2%
$466,547
162,560 shares
 — 31 Dec 2025
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
0.33%
$126,604
44,112 shares
 — 31 Dec 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
20
Shares
517,131
Rows available
20
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q1 2026 vs Q4 2025 Across Filers

Q4 2025 holders
19
Q1 2026 holders
20
Holder diff
1
Investor Q4 2025 Shares Q1 2026 Shares Share Diff Share Chg % Q4 2025 value Q1 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .